Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-03-15

Clinical Trial Update: Neural Mechanism of Aldosterone-induced Insulin Resistance [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating neural mechanisms of aldosterone-induced insulin resistance has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wanpen Vongpatanasin | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN